Anderson J, Rocchini A P
Division of Pediatric Cardiology, University of Minnesota Medical Center, Minneapolis.
Pediatr Clin North Am. 1993 Feb;40(1):93-104. doi: 10.1016/s0031-3955(16)38483-8.
Hypertension is known to place the individual with IDDM at high risk for the development of both renal and cardiovascular disease. Recent data suggest that aggressive antihypertensive therapy (angiotensin I converting enzyme inhibitors, prazosin, and calcium channel blockers) have significantly improved overall prognosis and long-term survival for individuals with IDDM. Because in individuals with IDDM the development of both hypertension and renal disease has its roots in childhood, it is important that early and effective antihypertensive treatment begin there.
